AEPBI
NVTA

AH Equity Partners Bio II’s Invitae Corporation NVTA Stock Holding History

AH Equity Partners Bio II’s Portfolio NVTA Stock Details NVTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3.14M Buy
1,276,541
+106,414
+9% +$323K 2.19% 4
2022
Q2 		$2.85M Hold
1,170,127
– – 2% 4
2022
Q1 		$9.33M Hold
1,170,127
– – 5.37% 4
2021
Q4 		$17.9M Buy
+1,170,127
New +$25.3M 9.3% 3

Other funds holding NVTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

AH Equity Partners Bio II's NVTA Position: Q3 2022 in Review

AH Equity Partners Bio II increased its Invitae Corporation (NVTA) stake by 9.1% in Q3 2022, buying an estimated $323K and bringing the position to 1,276,541 shares worth $3.14M. The position accounts for 2.19% of the portfolio, ranked #4.

AH Equity Partners Bio II first reported a position in NVTA in Q4 2021 and has held it in 4 quarters since. The position peaked at $17.9M in Q4 2021. 284 funds tracked by Wall St. Rank hold NVTA as of Q3 2022.

  • AH Equity Partners Bio II held 1,276,541 shares of Invitae Corporation worth $3.14M as of Q3 2022.
  • AH Equity Partners Bio II bought 106,414 Invitae Corporation shares in Q3 2022, an estimated $323K.
  • Invitae Corporation made up 2.19% of AH Equity Partners Bio II's portfolio in Q3 2022, its #4 holding.
  • AH Equity Partners Bio II first reported a position in Invitae Corporation in Q4 2021 and has held it in 4 quarters since.
  • AH Equity Partners Bio II's Invitae Corporation position peaked at $17.9M in Q4 2021.
  • 284 funds tracked by Wall St. Rank held Invitae Corporation as of Q3 2022.

Based on AH Equity Partners Bio II's 13F filing for Q3 2022, filed 14 Nov 2022.